Podcasts about advances

Ole Miss football took down Georgia, 39-34, to advance to the semifinals of the College Football Playoff. Ben Garrett and Brad Logan of the Ole Miss Spirit are LIVE from the Superdome with postgame coverage.Our Sponsors:* Check out Underdog Fantasy and use my code CHAMPIONS for a great deal: https://underdogfantasy.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

The 'Canes take down the Buckeyes and now head to the CFP Semifinals! Mac & KG recap the massive win for Miami. Presented by Ingles Markets. Sponsored by Rhoback, use code GMPOD for 20% off. Produced by Richmond Weaver

The State Department is now advancing its policies against mass migration, which it deems an existential threat to Western civilization. It is now looking for information on abuses of basic rights caused by people who migrate into other countries.In addition to this, the United States is also changing its policies on humanitarian aid at the United Nations. The goal, according to the State Department, is to save lives with less money.We'll discuss these topics, and others, in this episode of Crossroads.Views expressed in this video are opinions of the host and guests, and do not necessarily reflect the views of The Epoch Times.

Experts decode American Society of Nephrology (ASN) 2025 immunoglobulin A (IgA) nephropathy trials: B‑cell therapies, who benefits, and practical steps to improve patient care. Credit available for this activity expires: 12/24/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-advances-iga-nephropathy-key-developments-2025a100105j?ecd=bdc_podcast_libsyn_mscpedu

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of fascinating stories that underscore the dynamic nature of our industry, where scientific innovation meets real-world application.Starting with a significant advancement in gene therapy, researchers have made remarkable progress in a novel approach to treating rare genetic disorders. This new methodology involves the use of CRISPR technology to edit genes directly within the human body, paving the way for potential cures once thought impossible. By targeting specific DNA sequences, scientists can now correct genetic mutations at their source. This breakthrough not only promises to transform the treatment landscape for rare diseases but also enhances our understanding of genetic disorders at a molecular level. The implications here extend beyond rare conditions, potentially offering new avenues for tackling more common genetic diseases in the future.Moving forward, let's discuss recent regulatory developments that have caught the industry's attention. The FDA has granted accelerated approval to a new oncology drug that shows promise in treating advanced forms of breast cancer. This decision was based on compelling clinical trial results demonstrating significant improvements in patient survival rates compared to existing therapies. The drug targets specific proteins involved in tumor growth, offering a more precise treatment option with potentially fewer side effects. This approval exemplifies how regulatory bodies are adapting to expedite access to life-saving treatments while ensuring rigorous safety and efficacy standards.In another noteworthy development, a Phase III clinical trial has yielded positive results for a novel Alzheimer's drug. The trial demonstrated that this drug significantly slows cognitive decline in patients with early-stage Alzheimer's disease. By targeting amyloid plaques in the brain, which are believed to contribute to neurodegeneration, this therapeutic approach represents a potential shift in how we treat this debilitating condition. These findings provide hope for millions affected by Alzheimer's and underscore the importance of continued investment in neuroscience research.Turning our attention to infectious diseases, there's exciting news from a biotech company focusing on vaccine development. They've announced encouraging preliminary data from trials of their new mRNA-based vaccine for respiratory syncytial virus (RSV). RSV is known for causing severe respiratory illness, particularly in infants and the elderly. The vaccine demonstrated robust immune responses and a favorable safety profile, suggesting it could become an important tool in preventing RSV infections globally. This development highlights the versatility of mRNA technology, which has already revolutionized COVID-19 vaccine design and holds promise for addressing various infectious diseases.In terms of industry trends, one cannot overlook the growing emphasis on personalized medicine. Recent advancements in biomarker research are enabling more tailored therapeutic approaches across multiple disease areas. By identifying specific genetic or molecular markers associated with diseases, healthcare providers can better predict patient responses to certain treatments. This shift towards precision medicine not only improves patient outcomes but also enhances healthcare efficiency by reducing trial-and-error prescribing.Lastly, we delve into an intriguing area of metabolic disorders where innovative therapeutic strategies are emerging. A biotech firm has developed a first-in-class oral medication for treating non-alcoholic steatohepatitis (NASH), a serious liver condition linked to obesity and metabolic syndrome. The drug works by modulating key metabolic pathways involved in liver inflammation and fibrSupport the show

Twenty science stories from 2025 that you might have missed! The asteroid that's NOT going to hit earth. Exploring protein localization. Probing the sun. Pursuing nuclear fusion. ADHD and life expectancy. Sleeplessness and heart disease. Evolution of potatoes from tomatoes. New moons in our solar system. Exoplanet discoveries. The new human organelle. The Turing Test is passed. Feasibility of geoengineering. Influence of microbiome on infant brain development. Effect of COVID19 in male fathers on their offspring. A link between the common cold and COVID-19. Ocean acidification and environmental thresholds. Life on other planets. Pig organs successfully transplanted into people. Advances in synthesizing antimatter. Then hear about the planets, meteors, stars, nebulae, and constellations we can see in the night sky in January. ‘Bench Talk: The Week in Science' is a weekly program that airs on WFMP Louisville FORward Radio 106.5 FM (forwardradio.org) every Monday at 7:30 pm, Tuesday at 11:30 am, and Wednesday at 7:30 am. Visit our Facebook page for links to the articles discussed in this episode: https://www.facebook.com/BenchTalkRadio

In this episode of The Crop Science Podcast Show, Dr. Jian Jin from Purdue University explains how engineering, automation, and data-driven design are redefining sustainability and performance in modern agriculture. He explores how hyperspectral imaging, AI-based modeling, and robotic sensing systems contribute to crop management and resource efficiency in the field. Discover how innovation and circular thinking are building a more resilient and precise crop production system. Listen now on all major platforms!"Combining remote and proximal sensing creates a hybrid system that balances coverage, accuracy, and reliability in crop monitoring."Meet the guest: Dr. Jian Jin is an Associate Professor at Purdue University and President of LeafSpec LLC, specializing in agricultural and biological engineering. His research integrates imaging technologies, artificial intelligence, and automation to enhance plant phenotyping and precision agriculture.Liked this one? Don't stop now — Here's what we think you'll love!What you will learn:(00:00) Highlight(01:11) Introduction(03:55) Plant sensor lab(05:47) Optical sensor tech(09:40) Hyperspectral modeling(15:34) Industry applications(28:01) Scaling and automation(38:11) Final three questionsThe Crop Science Podcast Show is trusted and supported by innovative companies like:- KWS

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.Today, we dive into the latest breakthroughs and innovations shaping our industry. We start with a remarkable advancement in Alzheimer's disease treatment. A recent clinical trial has demonstrated significant progress in slowing cognitive decline among patients suffering from this challenging condition. The study, which involved a novel monoclonal antibody, showed promise by targeting amyloid plaques, a hallmark of Alzheimer's pathology. This approach not only opens new avenues for treatment but also provides hope for millions of patients and their families. The scientific community is closely monitoring these developments as they could redefine therapeutic strategies for neurodegenerative diseases.Moving on to regulatory news, the FDA has recently granted approval to a groundbreaking gene therapy for hemophilia B. This therapy represents a significant milestone as it offers a potential one-time treatment to correct the genetic defect underlying the disorder. By delivering a functional copy of the gene necessary for clotting factor production, patients may experience reduced bleeding episodes and improved quality of life. This approval underscores the FDA's commitment to advancing personalized medicine and highlights the transformative potential of gene therapies in addressing rare genetic conditions.In oncology, we've seen exciting progress with a novel targeted therapy showing efficacy in treating advanced stages of lung cancer. The drug specifically inhibits a mutation found in non-small cell lung cancer, which is often resistant to conventional treatments. Clinical trials have reported improved survival rates and better tolerability compared to existing therapies, marking a significant step forward in precision oncology. As researchers continue to unravel the complexities of cancer genomics, targeted therapies like this one offer new hope for patients battling aggressive forms of cancer.The biotech industry is also witnessing a surge in collaborations aimed at expediting vaccine development. In light of recent global health challenges, several companies have entered strategic partnerships to leverage their combined expertise in mRNA technology. These collaborations aim to accelerate the production and distribution of vaccines for infectious diseases beyond COVID-19. By pooling resources and sharing technological advancements, these alliances have the potential to enhance our preparedness for future pandemics and improve global public health outcomes.Shifting focus to autoimmune diseases, a novel small molecule inhibitor has shown potential in managing rheumatoid arthritis symptoms more effectively than traditional treatments. This new drug targets specific pathways involved in inflammation without compromising immune function. Early clinical data suggests it could offer patients relief with fewer side effects, representing a promising addition to the therapeutic arsenal against chronic inflammatory conditions.In an intriguing development within regenerative medicine, researchers have made strides in bioengineered organs. A recent breakthrough involves creating functional liver tissue from stem cells, paving the way for future organ transplantation solutions. These lab-grown tissues have demonstrated essential liver functions in preclinical models, bringing us closer to addressing organ shortages and enhancing transplant success rates. The implications of such advancements extend far beyond liver disease, offering transformative possibilities for regenerative therapies across various medical fields.Turning our attention to antimicrobial resistance, an ever-pressing concern within global health, scientists have discovered a new class of antibiotics capable of combating multidrug-resistant bacteria. This discovery comes atSupport the show

Aomori Yamada Advances to 2nd Round of Japan High School Soccer Tournament

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some fascinating breakthroughs and regulatory updates that are shaping the future of healthcare.Starting with a pivotal advancement in Alzheimer's research, a new drug has shown promising results in slowing cognitive decline in patients with early-stage Alzheimer's disease. This innovative therapy targets amyloid plaques in the brain, which are believed to play a central role in the progression of Alzheimer's. Recent clinical trials have demonstrated that patients receiving this treatment experienced a significant reduction in the rate of cognitive deterioration compared to those on a placebo. The implications of this development are profound, offering hope for millions affected by this debilitating condition. As researchers continue to unravel the mysteries of Alzheimer's, this breakthrough marks a crucial step forward in understanding and potentially halting disease progression.Moving on to regulatory news, the FDA has recently granted accelerated approval to a novel gene therapy for a rare genetic disorder known as spinal muscular atrophy (SMA). This condition, which affects motor neurons and leads to muscle wasting and weakness, primarily impacts infants and young children. The newly approved therapy works by delivering a functional copy of the defective gene directly into the patient's cells. Early trials have shown remarkable improvements in motor function and survival rates among treated infants. This approval represents not only a lifeline for affected families but also underscores the growing potential of gene therapies to address previously untreatable genetic diseases.In another significant development, researchers have unveiled a groundbreaking study on an experimental cancer vaccine that has demonstrated efficacy in preventing tumor growth in preclinical models. Unlike traditional vaccines aimed at infectious diseases, this cancer vaccine is designed to harness the body's immune system to specifically target and destroy cancer cells. The study's results indicate that the vaccine was successful in generating a robust immune response, which significantly inhibited tumor progression. If these findings can be replicated in human trials, it could open new avenues for cancer prevention and treatment, particularly for cancers with limited therapeutic options.Shifting our focus to trends within the industry, there's an increasing emphasis on personalized medicine, reflecting a broader shift towards treatments tailored to individual patients' genetic profiles. This approach aims to optimize therapeutic efficacy while minimizing adverse effects by considering each patient's unique genetic makeup. Advances in genomic sequencing technologies and bioinformatics are driving this transformation, enabling more precise diagnostics and targeted therapies. As personalized medicine continues to evolve, it holds the promise of revolutionizing how diseases are treated and managed in clinical practice.On the topic of drug approvals, a new oral medication for type 2 diabetes has received regulatory clearance after demonstrating superior glycemic control compared to existing treatments. This drug belongs to a novel class of medications that enhance insulin sensitivity and reduce glucose production by targeting specific metabolic pathways. Clinical trials indicated significant improvements in blood sugar levels and overall metabolic health among participants. Given the global prevalence of type 2 diabetes and its associated health complications, such advancements are crucial for improving patient outcomes and reducing healthcare burdens.Lastly, focusing on collaborations within the industry, several prominent pharmaceutical companies have announced partnerships aimed at accelerating research in infectious diseases.Support the show

In this special countdown episode, the EMJ Podcast team looks back at the 10 highest-performing episodes of 2025. Spanning neurology, cardiology, gastroenterology, women's health, respiratory medicine, and digital innovation, these conversations captured the topics that mattered most to clinicians worldwide. From chronic pain and anxiety to glucagon-like peptide-1 therapies, antimicrobial stewardship, and extended reality in medicine, this episode revisits the expert insights, emerging ideas, and clinical debates that shaped healthcare discussions throughout the year. Timestamps: 00:00 – Introduction: the year in review 01:52 – Gravity and human health 06:28 – Antimicrobial stewardship in children 10:15 – Healthcare communication and leadership 13:04 – Rare lung diseases and early diagnosis 16:56 – Colonoscopy and cancer prevention 21:17 – Extended reality in clinical care 25:25 – Advances in heart failure research 34:07 – Obesity management in the GLP-1 era 20:35 – Women's health across borders 39:40 – The pain–anxiety connection

Sky Women's Health grew.The podcast grew.Women's health moved forward.And I made some big, scary, values-aligned decisions.In this year-end episode, I'm reflecting on:• Growth without compromise• Advances in menopause & sexual health care• Meeting women where they are• Learning to get help• And asking myself: What would we do if we weren't scared?

In this episode of the Podcast of Champions hosts Ryan Abraham and David Woods are back to discuss the Oregon Ducks taking care of business against James Madison, advancing in the College Football Playoffs and putting three Big Ten programs into the quarterfinals. Dan Lanning and company jumped all over the Dukes early, but allowed 28 points in the second half including 14 in the final quarter that gave JMU the backdoor cover (much to the chagrin of our hosts). The guys look ahead to the rest of the Big Ten bowl games, previewing each of them and giving their picks against the spread. Northwestern, Minnesota, Penn State, Illinois, USC, Iowa, Michigan & Nebraska are all in action before the calendar turns to 2026. On New Year's Eve No. 2 Ohio State takes on No. 10 Miami in the Cotton Bowl and then on New Year's Day No. 5 Oregon faces No. 4 Texas Tech in the Orange Bowl and No. 1 Indiana faces No. 9 Alabama in the Rose Bowl. As always, they wrap up the podcast by answering listener email and live chat questions. For the video simulcasts of our POC please subscribe to your ⁠⁠⁠⁠⁠⁠⁠⁠YouTube channel⁠⁠⁠⁠⁠⁠⁠⁠! Please follow, give the POC a five-star rating and post a review on ⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠! ⁠⁠⁠⁠⁠⁠⁠⁠⁠You can bet all of the Big Ten games over at MyBookie! To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Dr Boyce speaks with Micah Smith about advances in Artificial Intelligence

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "Clinical Advances and Unanswered Questions in Narcolepsy," Lindsay McCullough, MD, discusses how clinical understanding of narcolepsy has evolved, where major diagnostic and treatment advances have occurred, and where important gaps remain. McCullough, assistant professor of medicine and associate program director for the sleep medicine fellowship at Rush University, reflects on progress in defining narcolepsy subtypes, the growing role of orexin biology, and how recent research in 2025 has reshaped conversations around disease-modifying approaches. The discussion also explores emerging links between sleep disorders and neurodegenerative disease, common misconceptions that continue to delay diagnosis, and how clinician education can improve recognition, safety, and long-term management of patients with narcolepsy. Looking for more Sleep Disorder discussion? Check out the NeurologyLive® Sleep Disorder clinical focus page. Episode Breakdown: 1:05 – Advances and remaining gaps in the clinical understanding of narcolepsy 2:30 – How narcolepsy care and research meaningfully evolved throughout 2025 4:50 – Sleep disorders, neurodegeneration, and what clinicians should watch for 6:50 – Neurology News Minute 8:50 – Persistent myths that delay diagnosis and affect clinical decision-making 12:30 – How lived experience shapes holistic, patient-centered narcolepsy care The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Inebilizumab for AChR- and MuSK-Positive Generalized Myasthenia Gravis FDA Clears Pivotal Phase 3 PREVAiLS Study of Pridopidine in Early, Rapidly Progressive ALS Tolebrutinib Falls Short in Phase 3 PERSEUS Study, Forcing Decision to Redact Regulatory Submission Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Masterpiece Audiobooks: Collection of Chinese Classic Novels

Masterpiece Audiobooks: Collection of Chinese Classic Novels

In this episode, producer Kailyn Bennett breaks down a new bipartisan housing bill that has advanced out of the House Financial Services Committee as lawmakers look for solutions to the housing affordability crisis. We cover what's included in the Housing for the 21st Century Act, how it aims to streamline zoning and permitting, and why expanding housing supply remains central to improving affordability.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Differences in Severity and Prognosis Between Bicuspid and Tricuspid Severe Aortic Stenosis.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Sex Differences in the Clinical Recognition of Significant Aortic Stenosis.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Cardiovascular-Kidney-Metabolic Syndrome-Attributable Mortality in the United States, From 2010 to 2023.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Long-Term Survival in Liver Transplant Patients With Coronary Artery Disease: A Multi-Institutional Study.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Association of Atrial Fibrillation Symptom Burden With Social Determinants of Health.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Ivabradine and Atrial Fibrillation Incidence: A Nested Matching Study.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 Diabetes.

 Endotrachael intubation is a highly important critical care procedure, and as such, clinicians are working to improve the procedure to ensure the best patient outcomes. As Stephanie DeMasi, MD, MS, assistant professor of emergency medicine at Vanderbilt University Medical Center, goes through the detailed review she wrote, along with her colleagues, on different evidence-based decisions clinicians face when intubating a patient, with host Eddie Qian, MD, Vanderbilt University Medical Center. Read Dr. DeMasi's paper, "Evidence-based Emergency Tracheal Intubation": https://www.atsjournals.org/doi/10.1164/rccm.202411-2165CI 

John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient Outcomes

John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient Outcomes

John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient Outcomes

The Alabama Crimson Tide beat the Oklahoma Sooners in the first round of the College Football Playoffs Friday night in Norman. Alabama Football fought back from down 17-0 to win 34-24 over Oklahoma Football. Alabama now advances to face the Indiana Hoosiers in the Rose Bowl on New Year's Day. We take an early look at that match-up for the Crimson Tide. Kalen DeBoer gets asked how the team was able to overcome a 17-point deficit Dunaway asks Kalen DeBoer about calling timeout before the pick 6 Ryan Grubb gets asked how they were able to make this comeback - credits SECCG loss and Ty Simpson and Deontae Lawson respond The Ole Miss Rebels smoked the Tulane Green Wave Saturday afternoon in Oxford. Ole Miss Football jumped out to a 17-3 halftime lead and never looked back. The Rebels now advance to face the Georgia Bulldogs in the Sugar Bowl on New Years Night. Pete Golding gets asked about fans chanting his name and about Charlie Weis Jr SUBSCRIBE: @NextRoundLive - / @nextroundlive FOLLOW TNR ON RUMBLE: https://rumble.com/c/c-7759604 FOLLOW TNR ON SPOTIFY: https://open.spotify.com/show/7zlofzLZht7dYxjNcBNpWN FOLLOW TNR ON APPLE PODCASTS: https://podcasts.apple.com/us/podcast/the-next-round/id1797862560 WEBSITE: https://nextroundlive.com/ MOBILE APP: https://apps.apple.com/us/app/the-next-round/id1580807480 SHOP THE NEXT ROUND STORE: https://nextround.store/ Like TNR on Facebook: / nextroundlive Follow TNR on Twitter: / nextroundlive Follow TNR on Instagram: / nextroundlive Follow everyone from the show on Twitter: Jim Dunaway: / jimdunaway Ryan Brown: / ryanbrownlive Lance Taylor: / thelancetaylor Scott Forester: / scottforestertv Tyler Johns: /TylerJohnsTNR Sponsor the show: sales@nextroundlive.com #SEC #Alabama #Auburn #secfootball #collegefootball #cfb #cfp #football #sports #alabamafootball #alabamabasketball #auburnbasketball #auburnfootball #rolltide #wareagle #alabamacrimsontide #auburntigers #nfl #sportsnews #footballnews Learn more about your ad choices. Visit megaphone.fm/adchoices

Are you regularly testing for TRK fusions in cancers with high fusion frequency? Credit available for this activity expires: 12/17/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-advances-trk-fusion-positive-cancers-2025a1000z5i?ecd=bdc_podcast_libsyn_mscpedu

Ben Garrett, Brad Logan and Sudu Upadhyay are LIVE for The Drive Home and after Ole Miss whipped Tulane for the second time this season to advance in the College Football Playoff.Our Sponsors:* Check out FRE and use my code LISTEN20 for a great deal: https://frepouch.com* Check out Underdog Fantasy and use my code CHAMPIONS for a great deal: https://underdogfantasy.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sarah Cogle, PharmD, BCNSP, FASPEN Evolving evidence supports the shift from single-source to multi-source intravenous lipid emulsions in parenteral nutrition. These newer formulations may offer improved metabolic, inflammatory, and hepatic outcomes, particularly for vulnerable patient populations. Joining Dr. Charles Turck to discuss the clinical rationale and operational considerations for these formulations is Dr. Sarah Cogle, who's a Clinical Pharmacist Specialist at Vanderbilt University Medical Center in Nashville, Tennessee.

Bryce Koon and Will Maness preview the first round of the college football playoff, giving their thoughts and predictions on each of the first round games. WEBSITE: https://thecrowdedbooth.substack.com/ MacArthur Woodworks: https://macarthurwoodworks.com/?srslt... SECTION103: https://www.section103.com/ MERCH: https://www.bonfire.com/store/the-cro... CAJUN COUSINS: https://cajuncousinsco.com/shop-2/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This episode explores the intersection of AI with healthcare, space innovation, and education. Preston and Seb discuss personalized genetic analysis, Google's space data centers, haptic touch tech, and the future of simulated realities. They also touch on AI bias, regulation, and how evolving tech might reshape society, purpose, and connection. IN THIS EPISODE YOU'LL LEARN: 00:00:00 - Intro 00:05:20 - How genetic data is used to create custom supplement plans 00:07:21 - The role of AI in interpreting genetic information 00:16:21 - Why Google's space-based data centers could revolutionize computing 00:19:55 - Technical challenges of Bitcoin mining in orbit 00:24:17 - The implications of space debris and Kessler Syndrome 00:26:11 - How AI is personalizing education through initiatives like "Learn Your Way" 00:30:35 - Pros and cons of VR and humanoid robots in classrooms 00:38:45 - Ethical concerns around AI bias and centralization of regulation 00:54:37 - Advances in haptic touch technology for VR and robotics 00:50:12 - Philosophical questions about simulations, reality, and technology's impact on society Disclaimer: Slight discrepancies in the timestamps may occur due to podcast platform differences. BOOKS AND RESOURCES Seb's book: ⁠⁠⁠The Hidden Cost of Money⁠⁠⁠. X Account: ⁠⁠Seb Bunney⁠⁠. Related⁠⁠⁠⁠⁠⁠⁠⁠⁠ books⁠⁠⁠⁠⁠⁠⁠⁠⁠ mentioned in the podcast. Ad-free episodes on our⁠⁠⁠⁠⁠⁠⁠⁠⁠ Premium Feed⁠⁠⁠⁠⁠⁠⁠⁠⁠. NEW TO THE SHOW? Join the exclusive ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TIP Mastermind Community⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to engage in meaningful stock investing discussions with Stig, Clay, Kyle, and the other community members. Follow our official social media accounts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠X (Twitter)⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Check out our ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bitcoin Fundamentals Starter Packs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Browse through all our episodes (complete with transcripts) ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Try our tool for picking stock winners and managing our portfolios: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TIP Finance Tool⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Enjoy exclusive perks from our ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠favorite Apps and Services⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Get smarter about valuing businesses in just a few minutes each week through our newsletter, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Intrinsic Value Newsletter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Learn how to better start, manage, and grow your business with the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠best business podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. SPONSORS Support our free podcast by supporting our ⁠sponsors⁠: Simple Mining Human Rights Foundation Unchained HardBlock Linkedin Talent Solutions Onramp Amazon Ads Alexa+ Shopify Vanta Public.com - see the full disclaimer here. Abundant Mines Horizon Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://theinvestorspodcastnetwork.supportingcast.fm

This week on Health Matters, we're sharing an episode of NewYork-Presbyterian's Advances in Care, a show for listeners who want to stay at the forefront of the latest medical innovations and research. On this episode of Advances in Care, host Erin Welsh first hears from Dr. Richard Friedman, a clinical psychiatrist at NewYork-Presbyterian and Director of the Psychopharmacology Clinic at Weill Cornell Medicine. Using his background in psychopharmacology, Dr. Friedman distinguishes between psychedelics and standard antidepressants like SSRIs and SNRIs, explaining the various mechanisms in the brain that respond uniquely to psychedelic compounds. Dr. Friedman also identifies that the challenge of proving efficacy of psychedelic therapy lies in the question of how to design a clinical trial that gives patients a convincing placebo. To learn more about the challenges of trial design, Erin also speaks to Dr. David Hellerstein, a research psychiatrist at NewYork-Presbyterian and Columbia. Dr. Hellerstein contributed to a 2022 trial of synthetic psilocybin in patients with treatment resistant depression. He and his colleagues took a unique approach to dosing patients so that they could better understand the response rates of patients who use psychedelic therapy. The results of that trial underscore an emerging pattern in the field of psychiatry – that while psychedelic therapy has its risks, it's also a promising alternative treatment for countless psychiatric disorders. Dr. Hellerstein also shares more about the future of clinical research on psychedelic therapies to potentially treat a range of mental health disorders.***Dr. Richard Friedman is a professor of clinical psychiatry and is actively involved in clinical research of mood disorders. In particular, he is involved in several ongoing randomized clinical trials of both approved and investigational drugs for the treatment of major depression, chronic depression, and dysthymia.Dr. David J. Hellerstein directs the Depression Evaluation Service at Columbia University Department of Psychiatry, which conducts studies on the medication and psychotherapy treatment of conditions including major depression, chronic depression, and bipolar disorder.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

Advances in quantum computing are based on fundamental scientific advances in condensed matter physics. On this episode, Dr. Steven Chu discussed cooling atoms with lasers, from an interview originally broadcast 02.25.04.

John Hardie discusses US pressure on Ukraine to withdraw from Donetsk and drop NATO bids for peace. He details Russian advances near Pokrovsk but doubts their ability to capture remaining fortress cities. Hardie notes Ukrainian resistance to territorial concessions despite Russian battlefield initiative and Western diplomatic maneuvering. 1859 Odessa

Polly James is at Alexandra Palace to take a look back at the action from Day 6 of the World Darts Championships.Tuesday saw Gerwyn Price, Chris Dobey and Danny Noppert all enter the tournament.Sky customers can watch all the darts at home or on the Sky Sports App. Non-Sky customers can stream the action with a flexible NOW day or month pass.Love The Darts is a Sky Sports podcast. Listen to every episode here: skysports.com/love-the-dartsYou can listen to Love The Darts on your smart speaker by saying "ask Global Player to play Love The Darts".For all the latest darts news, head to skysports.com/dartsFor advertising opportunities email: skysportspodcasts@sky.uk

Erwan Donal, MD, PhD / Nina Ajmone Marsan, MD, PhD - At the Cutting Edge of ATTR-CM: How Can We Leverage Advances in Multimodality Cardiac Imaging and Artificial Intelligence to Modernise Diagnosis and Monitoring?

A second ballot initiative that would ensure Montana's judicial elections are nonpartisan is advancing. The initiative was tied up in court when its backers and Attorney General Austin Knudsen disagreed over its wording.

Listen in as Jay H. Shubrook, DO, FACOFP, FAAFP, and Chrisopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA, discuss the latest advances in caring for patients with overweight or obesity in the primary care setting, including:The Lancet Commission's new obesity definitions and diagnostic criteriaKey data on incretin-based antiobesity medications like semaglutide and tirzepatideBest practices for patient discussionsStrategies for incorporating new evidence in your primary care practicePresentersJay H. Shubrook, DO, FACOFP, FAAFPProfessor and DiabetologistDepartment of Clinical Sciences and Community HealthTouro University California College of Osteopathic MedicineVallejo, CaliforniaChristopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMABariatric Services Medical Director, Ascension WisconsinObesity Medicine Director, Ascension Columbia St Mary's Bariatric CenterTrustee, Obesity Medicine AssociationAdjunct Assistant Professor of PediatricsMedical College of WisconsinMilwaukee, WisconsinLink to full program:https://bit.ly/4rG7QQp Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Mapping the Sun's Corona and Rethinking Ice Giants: Colleague Bob Zimmerman details scientific advances including mapping the sun's corona and rethinking Uranus and Neptune as having rocky interiors rather than just ice, mentioning discoveries regarding supernova composition, the lack of supermassive black holes in small galaxies, and new images of Mars' polar ice layers. 1950

Subscribe now to skip the ads and get all of our episodes. Listen to our Chinese Prestige miniseries! Danny and Derek will sadly not be doing a CBS News town hall event. This week in the news: the Thailand–Cambodia conflict resumes (1:47); the DRC–M23 conflict also resumes as M23 makes new advances (7:05); in Gaza, questions remain over the “second phase” of the ceasefire as a winter storm hits (10:38); separatists in Yemen gain control of the country's south (17:18); the RSF takes Sudan's largest oilfield (21:02); an attempted coup is foiled in Benin (23:31); Trump gives NATO a 2027 ultimatum on defense spending (26:05); Ukraine responds to the U.S. peace plan while Trump expresses frustration (29:46); controversy erupts in Honduras over election ballot-counting snafus (35:56); and in these great United States, Congress removes “right to repair” from the NDAA after contractors lobby against it (38:53). Don't forget to join out our Discord.

Subscribe now to skip the ads and get all of our episodes.Listen to our Chinese Prestige miniseries!Danny and Derek will sadly not be doing a CBS News town hall event. This week in the news: the Thailand–Cambodia conflict resumes (1:47); the DRC–M23 conflict also resumes as M23 makes new advances (7:05); in Gaza, questions remain over the “second phase” of the ceasefire as a winter storm hits (10:38); separatists in Yemen gain control of the country's south (17:18); the RSF takes Sudan's largest oilfield (21:02); an attempted coup is foiled in Benin (23:31); Trump gives NATO a 2027 ultimatum on defense spending (26:05); Ukraine responds to the U.S. peace plan while Trump expresses frustration (29:46); controversy erupts in Honduras over election ballot-counting snafus (35:56); and in these great United States, Congress removes “right to repair” from the NDAA after contractors lobby against it (38:53).Don't forget to join our Discord.Our Sponsors:* Check out Avocado Green Mattress: https://avocadogreenmattress.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Read the full show notes: https://www.draimee.org/from-patient-connection-to-policy-change-advancing-fertility-amp-ivf-care-in-the-u-s-with-guest-kaylen-silverberg-md In this episode of The Egg Whisperer Show, I'm thrilled to welcome Dr. Kaylen Silverberg, medical director and managing partner at Texas Fertility Center, co-founder of Ovation Fertility, and a leading advocate for patients navigating IVF and reproductive medicine in the United States. Dr. Silverberg shares his journey from aspiring heart surgeon to passionate fertility specialist, and how his deep connections with patients inspired him to bridge the gap between clinical care and national policy change. Watch this episode on YouTube. In this episode, we cover: Dr. Silverberg's personal journey from heart surgery to reproductive medicine The power of patient stories in influencing national policy and lawmakers The mission and current legislative efforts of Americans for IVF Recent changes and proposals to make fertility medications and IVF more affordable The impact of bipartisan advocacy and the importance of building relationships with representatives Advances in endometriosis research and its effect on fertility The promise and limitations of genetic testing in IVF How listeners can get involved in advocacy and make their voices heard Resources: Texas Fertility Center: https://www.txfertility.com Americans for IVF: https://americansforivf.org Resolve: The National Infertility Association: https://resolve.org American Society for Reproductive Medicine: https://asrm.org Dr. Silverberg's Instagram: https://www.instagram.com/lets_talk_about_fertility/ Subscribe to The Egg Whisperer Show on YouTube and Spotify Join Dr. Aimee's IVF Class at The Egg Whisperer School Learn About Dr. Aimee's Fertility Essentials

Fragmentation in Yemen: The Southern Transitional Council Advances: Colleagues Bridget Tumi and Bill Roggio report that the civil war in Yemen is fracturing further as the Southern Transitional Council, which advocates for southern secession, advances into eastern governorates to secure territory and combat smuggling; this move has heightened tensions within the anti-Houthi coalition, as the STC is backed by the UAE while other government factions are supported by Saudi Arabia, weakening the collective effort against the Houthis who control thYEMEN800 e capital Sanaa and maintain ambitions to conquer the entire country. 1800 YEMEN

Today, I'm joined once again by the incredible Dr. Bill Lawrence, a true pioneer in the field of longevity research and one of the most requested guests on this podcast. Dr. Lawrence trained directly with Professor Vladimir Khavinson—the scientist who discovered and developed bioregulator peptides—and has spent the last eight years leading some of the most exciting field research in this space.   Episode Timestamps: Welcome and introduction to Longevity Podcast ... 00:00:00 Origins and early use of bioregulator peptides in Soviet research ... 00:05:39 Organ-specific peptide mechanisms and targeting ... 00:08:28 Dr. Lawrence's collaboration with Professor Cavinson ... 00:12:17 Overview of American clinical studies and study protocols ... 00:14:13 Measuring biological age: telomeres and epigenetic markers ... 00:15:06 Key Russian studies and impact of peptides on mortality ... 00:17:00 Peptides as ultimate epigenetic switches and DNA repair ... 00:20:00 Importance of pineal and thymus peptides in protocols ... 00:22:28 Advances in peptide testing and lab beta-testing ... 00:28:05 Clinical outcomes: organ regeneration and normalized function ...00:35:54 Bioregulator peptides vs. synthetics: modulation vs. boosting ... 00:39:28 Dr. Lawrence's personal telomere and epigenetic age results ... 01:07:56 Impact of stress and meditation on telomere length ... 01:10:37 Group results: significant telomere and epigenetic age reversal ... 01:13:03 System-level organ age tracking and protocol targeting ... 01:27:14 International expansion and next steps in peptide research ... 01:37:03   Our Amazing Sponsors:   Kineon - near-infrared light helps improve circulation, oxygen delivery, and mitochondrial function, which can support focus, recovery, and even overall brain health. Visit kineon.io/NATNIDDAM and get 10% off!   BEAM Minerals - Mineral deficiency support. One shot in the morning, tastes like water, and you've just restored every essential mineral your cells are craving. Go to beamminerals.com, use code NAT20, and get 20% off your first order.   Nootropept by LVLUP - an advanced cognitive enhancement formula that combines fast-acting neuropeptides, cholinergic support, and mitochondrial-boosting compounds to sharpen mental clarity, memory, and long-term brain performance. Visit https://lvluphealth.com/ and use code NAT at checkout for 20% off.   Nat's Links:  YouTube Channel Join My Membership Community Sign up for My Newsletter  Instagram  Facebook Group

EVERYONE who signs up wins a FREE toy or gift card!  ⁠⁠https://www.bboutique.co/vibe/emilymorse-podcast Try Timeline today! Text “EMILY” to 57237 and claim your FREE 3-day Trial of Gummies. Your cells will thank you! Magnesium, multiplied. 10 forms for total support. Go to ⁠https://qualialife.com/SEXWITHEMILY⁠ to get 50% off and save an extra 15% with the code SEXWITHEMILY. Sponsored by Je Joue https://www.jejoue.com/products/hera-flex-rabbit-vibrator?utm_source=SWE-HeraFLEXPODCAST&utm_medium=SWE-HeraFLEXPODCAST Join the SmartSX Membership : https://sexwithemily.com/smartsx Access exclusive sex coaching, live expert sessions, community building, and tools to enhance your pleasure and relationships with Dr. Emily Morse. List & Other Sex With Emily Guides: https://sexwithemily.com/guides/ Explore pleasure, deepen connections, and enhance intimacy using these Sex With Emily downloadable guides. SHOP WITH EMILY!: https://bit.ly/3rNSNcZ (free shipping on orders over $99) Want more? Visit the Sex With Emily Website: https://sexwithemily.com/ Episode Description In this Sex with Emily episode, Dr. Emily and producer Erica tackle your trickiest relationship and sex questions—and some of these situations are messier than you think. The wife having sex 5+ times a week who's being pressured to set midnight alarms so her husband can wake her up for more—why this isn't about frequency at all, and the real need he's actually trying to fill. That guy who insists oral sex should only happen "on special occasions" because it gets "taken for granted": what this scarcity mindset reveals about his past relationships, his skill anxiety, or his actual preference—and whether this is a dealbreaker you're discovering early. The biological reason men wake up ready for sex in the middle of the night while their partners are deep asleep—and why disrupting your sleep hygiene to feel "desired" is a Band-Aid on a much deeper issue. When your partner believes doing something too often creates expectations they can't meet: the philosophy problem that shows up in bed and everywhere else, and what "taken for granted" really means about their view on compliments, effort, and intimacy. Why oral sex as foreplay is the norm, not the exception—and how to navigate a partner who sees it as the main event that loses its magic with repetition. Plus: the conversation framework for exploring where your partner's sexual beliefs actually come from, and why the first few months of dating are just data collection on whether you're actually compatible. Timestamps: 0:00 - Introduction 1:01 - Question 1: Rejecting Partner's Advances in the Middle of the Night 6:42 - Understanding Nocturnal Erections and Gender Differences in Arousal 10:10 - Question 2: Feeling Done with a Sexless Marriage After 7 Years 16:20 - Question 3: Getting Upset When Partner Doesn't Want Sex (Mismatched Libidos) 21:28 - Question 4: Dealing with Low Libido and Performance Anxiety at 42 25:10 - Question 5: Wanting Oral Sex Every Time, Not Just Special Occasions 32:52 - Closing Thoughts and How to Connect with Dr. Emily